hematological disorders

Interview
Improving Access to Quality Cancer Care Close to Home
12/13/2016
JCP Editors
Patients with cancer are often forced to choose between seeking specialized medical treatment at facilities located a significant distance from their homes or accepting less rigorous care at local treatment centers....
Patients with cancer are often forced to choose between seeking specialized medical treatment at facilities located a significant distance from their homes or accepting less rigorous care at local treatment centers....
...
12/13/2016
Journal of Clinical Pathways
Conference Coverage
ASH Annual Meeting and Exposition
12/06/2016
JCP Editors
Founded in 1958, the American Society of Hematology (ASH) is considered the premier professional society for physicians and scientists specializing in benign and malignant blood disorders. The organization is...
Founded in 1958, the American Society of Hematology (ASH) is considered the premier professional society for physicians and scientists specializing in benign and malignant blood disorders. The organization is...
...
12/06/2016
Journal of Clinical Pathways
Few Blood Cancer Patients Receive Recommended CINV Prophylaxis
11/30/2016
JCP Editors
Many patients with hematologic cancers receiving highly emetic chemotherapy regimens do not achieve adequate control of chemotherapy-induced nausea and vomiting (CINV), according to study results presented at the...
Many patients with hematologic cancers receiving highly emetic chemotherapy regimens do not achieve adequate control of chemotherapy-induced nausea and vomiting (CINV), according to study results presented at the...
Many...
11/30/2016
Journal of Clinical Pathways
ASCO, ESMO Value Frameworks Imperfectly Apply to Hematology
11/30/2016
JCP Editors
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
...
11/30/2016
Journal of Clinical Pathways
Regret-Based Decision Model Helpful Tool for Palliative Care Discussions
11/30/2016
JCP Editors
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The...
11/30/2016
Journal of Clinical Pathways
Slow Implementation of Value-Based Care
11/30/2016
JCP Editors
In 2012, the American Board of Internal Medicine launched the Choosing Wisely campaign, which attempts to curb wasteful medical spending by limiting the use of unnecessary tests and procedures. Prominent medical...
In 2012, the American Board of Internal Medicine launched the Choosing Wisely campaign, which attempts to curb wasteful medical spending by limiting the use of unnecessary tests and procedures. Prominent medical...
In...
11/30/2016
Journal of Clinical Pathways
Inappropriate Thrombophilia Testing Remains High Among Hospital Inpatients
11/30/2016
JCP Editors
Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to...
Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to...
...
11/30/2016
Journal of Clinical Pathways
Research in Review
Prior Malignancies Do Not Affect CML Outcomes
11/02/2016
JCP Editors
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
...
11/02/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use